Emelie Curovic Rotbain (Emelie Rotbain, Emelie C Rotbain)

ResearcherID Researcher ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Chronic Lymphocytic Leukemia

Gas Chromatography

Top Venues

Clinical epidemiology

Access microbiology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Esben Packness, Olafur Birgir Davidsson, Klaus Rostgaard, Michael Asger Andersen, Emelie Curovic Rotbain, Carsten Utoft Niemann, Christian Brieghel, Henrik Hjalgrim
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma. British journal of cancer (2024)
Emelie Curovic Rotbain, Cristine Allmer, Klaus Rostgaard, Michael Asger Andersen, Noomi Vainer, Caspar da Cunha-Bang, Sameer A Parikh, Kari G Rabe, Henrik Hjalgrim, Henrik Frederiksen, Susan L Slager, Carsten Utoft Niemann
Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia. American journal of hematology (2023)
Matilde Slot, Carsten Utoft Niemann, Lars Holger Ehlers, Emelie Curovic Rotbain
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naïve unfit CLL without TP53 aberrations. Blood advances (2023)
Noomi Vainer, Kathrine Aarup, Michael Asger Andersen, Lise Wind-Hansen, Tine Nielsen, Henrik Frederiksen, Lisbeth Enggaard, Christian Bjørn Poulsen, Carsten Utoft Niemann, Emelie Curovic Rotbain
Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia. British journal of haematology (2023)
Emelie Curovic Rotbain, Max J Gordon, Noomi Vainer, Henrik Frederiksen, Henrik Hjalgrim, Alexey V Danilov, Carsten Utoft Niemann
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research. Blood advances 6 (8) (2022)
Emelie Curovic Rotbain, Caspar da Cunha-Bang, Christian Brieghel, Carsten Utoft Niemann
CLL-IPI applied in Binet A CLL: a nationwide cohort study. Blood advances 6 (21) (2022)
Kasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, Anne Broe, Emelie Curovic Rotbain, Per Damkier, Jesper Hallas, Jacob Harbo Andersen, Mikkel Højlund, Morten Olesen, Lotte Rasmussen, Morten Rix Hansen, Martin Thomsen Ernst, Rikke Wesselhoeft, Daniel Pilsgaard Henriksen, Mette Reilev, Mette Bliddal, Nina Sahlertz Kristiansen
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical epidemiology 14 (2022)
Emelie Curovic Rotbain, Carsten Utoft Niemann, Klaus Rostgaard, Caspar da Cunha-Bang, Henrik Hjalgrim, Henrik Frederiksen
Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death. Leukemia 35 (9) (2021)
Emelie Curovic Rotbain, Klaus Rostgaard, Michael A Andersen, Caspar Da Cunha-Bang, Carsten Utoft Niemann, Henrik Frederiksen, Henrik Hjalgrim
Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia. Clinical epidemiology 13 (2021)
Caroline Gren, Malene Roed Spiegelhauer, Emelie Curovic Rotbain, Boje Kvorning Ehmsen, Peter Kampmann, Leif Percival Andersen
Ruminococcus gnavus bacteraemia in a patient with multiple haematological malignancies. Access microbiology 1 (8) (2019)
Emelie Curovic Rotbain, Dennis Lund Hansen, Ove Schaffalitzky de Muckadell, Flemming Wibrand, Allan Meldgaard Lund, Henrik Frederiksen
Splenomegaly - Diagnostic validity, work-up, and underlying causes. PloS one 12 (11) (2017)